Capture Your Research! is an image competition where students, faculty, and staff can submit one image that captures the essence of their research. They will be judged on originality/creativity, appeal of the image, relationship between the image and their research, and the clarity of the written description. Deadline: Oct. 13

The Brain Lesion and Neuromodulation Laboratory (BLNL) investigates neural mechanisms of cognition and behavior. We do so primarily using lesion-deficit mapping, and brain stimulation (i.e., "neuromodulation"). Current topics of interest in the BLNL include: linking cognitive and personality changes to brain network damage in patients with focal brain lesions (e.g., in patients who have had a stroke), and using direct electrical stimulation of the brain in neurosurgical patients to alter brain network connectivity and cognition. We are also broadly interest in topics that span clinical neuropsychology and cognitive neuroscience.

Applications being accepted for travel awards for conferences or professional development workshop travel or other professional creative activities for undergraduates. Awards are one time only, up to $500.

We are looking for enthusiastic and motivated undergraduate students who are interested in immunology and want to investigate intestinal mucosa in two disease models, namely graft-versus-host disease and inflammatory bowel disease.

Our projects are captured by the question “How do the different kinds of cells work together in an epithelium to orchestrate ion transport?”. Duties include making solutions, help in preparing experiments, and mouse genotyping.

Shahi lab studies how obesity influences the immune system, gut microbiota, and brain health, with a special focus on multiple sclerosis (MS). He investigates: How obesity-driven changes in gut bacteria increase hydrogen sulfide (H₂S) production, altering immune cell activity and worsening inflammation. How these mechanisms disrupt gut–brain communication and contribute to MS severity. Translating these findings into new microbiome- and metabolism-targeted therapies for MS.